OptiStrata™ Stratifies Cancer Risk
From Top to Bottom
Optinosis helps risk-bearing payers and providers save millions of dollars annually by reducing the total cost of care associated with late-stage cancer treatments.
Our OptiStrata software identifies patients who are 95+% likely to have currently undiagnosed cancer, enabling more effective screening, much earlier diagnosis and less costly treatments.
Potential customers can quickly confirm its accuracy in a no-cost proof of concept.
Improve Risk-Bearing Payer and Provider Outcomes
Most risk-bearing payers and providers fail to proactively manage their single most destructive cost event: late-stage cancer.
There is no other condition in the medical expense budget with this combination of high variance and risk exposure.
Identify Hidden Cancer Risks
OptiStrata finds currently undiagnosed cancers hidden in your population.
By identifying these individuals before they present as late-stage emergencies, you enable more treatments at Stage I or II — producing demonstrable ROI for risk-bearing entities.y to have undiagnosed cancer.
Advance Health Equity
OptiStrata advances health equity by using claims data to identify undiagnosed cancer risks in often underserved seniors in rural, low-income, or minority communities with limited screening access.
OptiStrata also uncovers disparities invisible to traditional risk models — prioritizing high-need patients, shifting diagnoses earlier, and reducing late-stage treatment costs that disproportionately burden vulnerable groups.
Request a No-Cost Proof of Concept
Potential customers can quickly confirm the financial and clinical benefits of early cancer detection with a no-cost proof of concept. Simply share your existing claims data with our team.